A previous study reported that several GPCRs, including GPR50, are involved in the reprogramming of somatic cells to BCSCs, suggesting that GPR50 can act as a tumor suppressor in hepatocellular carcinoma (HCC) through the ADAM17-Notch signaling pathway [14,15]. The gene discussed is ADAM17; the disease is hepatocellular carcinoma.